Main
Jake Earl
Pharmacist (PharmD), and Health Economist (MS) with clinical and payor expertise and in-depth training in Health Economics and Outcomes Research (HEOR).
I have worked for a Managed Care Organization, a research hospital, and a large pharmaceutical company. I have built and analyzed various economic models and conducted various Real-World Evidence (RWE) studies utilizing claims data. My knowledge is always growing and includes biostatistics, epidemiology, and coding with R, SAS, SQL, and VBA. My goal is to generate impactful research that depicts a clear message and ultimately become a leader within my field.
Education
Master of Science, Health Economics and Outcomes Research
University of Washington CHOICE Institute
Seattle, WA
2024 - 2023
- Post-Doctoral Fellow
- Master’s Thesis: Identifying and Characterizing Commercially Insured HFpEF Patients with High vs. Low Utilization doi: 10.18553/jmcp.2025.31.8.741
Doctor of Pharmacy
University of Utah College of Pharmacy
Salt Lake City, UT
2023 - 2019
- Viatris Excellence in Pharmacy Award Recipient
- 2023 AFPE Research Scholarship Nominee (one of two from the college)
- Conducted Research with the Pharmacy Outcomes Research Center (PORC)
Industry Experience
Senior Manager HEOR Strategy
Bayer Pharmaceuticals
Whippany, NJ
2025 (current)
- Conceptualized impactful RWE studies
- Generated scientifically valid study designs that contained risk mitigation strategies
- Assessed different types of available data to ensure the research could be completed properly
- Ensured RWE activities were completed in a timely manner for Kerendia launch
- Delivered simple, impactful presentations
Post-Doctoral Fellow, HEOR & Data Analytics
Bayer Pharmaceuticals
Whippany, NJ
2025 - 2023
- Conceptualized, designed, and managed RWE studies supporting the launch of Kerendia utilizing various databases
- Assessed data capabilities and ensured methodology was scientifically sound
- Presented research proposals for internal alignment and approval
- Generated simple and impactful messages from complex data for external communication with HCEI decks and RWE posters
- Assessed economic models and presented on their function and validity
Post-Doctoral Fellow, HEOR
University of Washington CHOICE Institute / Bayer
Seattle, WA
2024 - 2023
- Generated advanced Markov Models using VBA in Excel for PSA & VOI analyses
- Conducted RWE research utilizing R, SAS, and SQL with MarketScan data
- Utilized advanced methodology in Biostatistics, Epidemiology, and Data Analysis for application in HEOR
Pharma Consulting, Pharmacist Intern Advanced Experience
Cencora
Carrollton, TX
2023 (6wks)
- Analyzed pharmaceutical companies and evaluated the impact of their therapies
- Developed clear and impactful presentations for clients
- Followed new legislation and delivered internal presenations for education
Managed Care, Pharmacist Intern Advanced Experience
University of Utah Health Plans
Salt Lake City, UT
2023 - 2021
- Analyzed new therapies and presented to P&T committee
- Revised and developed prior-authorization (PA) criteria
- Analyzed claim data to determine adherence and evaluate coverage
- Examined PA appeals in oncology and other therapeutica areas to determine approval or denial
- Networked with KOLs to obtain specialized perspective
Inpatient Clinical Pharmacist Intern Advanced Experience
University of Utah Health Hospital
Salt Lake City, UT
2023 - 2019
- Analyzed data of drug utilization and optimized medication cabinets
- Identified gaps in care with medication reconciliations
- Gave presentations to patient groups and educated individual patients on guideline-directed therapies across all units in the hospital
Pharma Industry, Pharmacist Intern Advanced Experience
Ionis Pharmaceuticals
Carlsbad, CA
2022 (6wks)
- Analyzed new therapies for rare diseases and helped determined gaps in research
Research Publications
Identifying and Characterizing Commercially Insured HFpEF Patients with High vs. Low Utilization
Jacob Earl, Laura Hart, Ryan Hansen
N/A
2025
Cost-Effectiveness Analysis of Five Anti-Obesity Medications from a US Payer’s Perspective
Ainhoa Gomez-Lumbreras, Malinda S Tan, Lorenzo Villa Zapata, Sabrina Ilham, Jacob Earl, Daniel C Malone
N/A
2023
Genetic Biomarkers in Multiple Sclerosis: An Umbrella Review of Meta-Analyses of Observational Studies
Adelaide Tempest, Sajesh K Veettil, Mari Kannan Maharajan, Jacob Earl, Surachat Ngorsuraches, Nathorn Chaiyakunapruk
N/A
2022
Posters & Conference Presentations
Real-World (RW) treatment patterns and clinical outcomes of patients treated with sequential regorafenib (R) and trifluridine/tipiracil (T) ± bevacizumab (BEV) for metastatic colorectal cancer (mCRC) in the United States (US) community oncology setting: The SEQRT2 study
Abstract and Poster Presentation at ASCO Genitourinary Symposium
N/A
2025
Utilization of Guideline-Directed Medical Therapies in finerenone users
Poster Presentation at American Society of Nephrology Kidney Week
N/A
2024
Utilization of non-steroidal Mineralocorticoid Receptor Antagonist (MRA) finerenone with or without prior steroidal MRA
Poster Presentation at American Society of Nephrology Kidney Week
N/A
2024
Healthcare Resource Utilization Among Adults in North America with Heart Failure
Poster Presentation at Corporate Advisory Board Meeting
N/A
2023
The Effects of Bupropion in the Brains of Mice with METH-induced toxicity
Poster Presentation at the Society for Neuroscience
N/A
2023
Learning from Learners: A Proactive Mindset to Improve
Oral presentation at both UPHA and USHP Annual Meetings
N/A
2023
Leadership Experience
Diabetes Empowerment Program (DEP) Pharmacist Representative
Midvalley Community Clinic
Murray, Utah
2023 - 2022
- Generated educational slide decks and presented content in Spanish
Project & Research Development Teaching Assistant
University of Utah College of Pharmacy
Salt Lake City, Utah
2023 - 2022
- Mentored and educated students in presentation of research and methodology
Maliheh Community Clinic Director
Maliheh Community Clinic
Millcreek, Utah
2022 - 2021
- Expanded clinic and provided free care to the underserved population